DebraLee(Kingsborough)HannaMD

PubMed

• 15 citations
  Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-Na...
  Eric L. Nuermberger, Christine Sizemore, Klaus Romero, Debra Hanna> ;Antimicrobial Agents and Chemotherapy. 2016 Mar 1
• 24 citations
  Front-Loaded Linezolid Regimens Result in Increased Killing and Suppression of the Accessory Gene Regulator System of Staphylococcus aureus
  Brian T. Tsuji, Tanya Brown, Ridhi Parasrampuria, Daniel A. Brazeau, Alan Forrest, Pamela A. Kelchlin, Patricia N. Holden, Charles A. Peloquin, Debra Hanna, Jürgen B. ...> ;Antimicrobial Agents and Chemotherapy. 2012 Jul 1
• 2 citations
  Evaluation of Pharmacokinetic/Pharmacodynamic Relationships of PD-0162819, a Biotin Carboxylase Inhibitor Representing a New Class of Antibacterial Compounds, Using In...
  Adam Ogden, Michael Kuhn, Michael Dority, Susan Buist, Shawn Mehrens, Tong Zhu, Deqing Xiao, J. Richard Miller, Debra Hanna> ;Antimicrobial Agents and Chemotherapy. 2012 Jan 1
• 42 citations
  5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.
  Jeremy T. Starr, Richard J. Sciotti, Debra Hanna, Michael D. Huband, Lisa Mullins, Hongliang Cai, Jeffrey W. Gage, Mandy Lockard, Mark R. Rauckhorst, Robert M. Owen, M...> ;Bioorganic & Medicinal Chemistry Letters. 2009 Sep 15
• 16 citations
  Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid am...
  Poel Toni-Jo, Thomas Richard C, Wade J. Adams, Aristoff Paul A, Barbachyn Michael R, Frederick E. Boyer, Joan K. Brieland, Roger J. Brideau, Joanne Brodfuehrer, Alan P...> ;Journal of Medicinal Chemistry. 2007 Nov 8
• 52 citations
  In Vitro and In Vivo Activities of PD 0305970 and PD 0326448, New Bacterial Gyrase/Topoisomerase Inhibitors with Potent Antibacterial Activities versus Multidrug-Resis...
  Michael D. Huband, Michael A. Cohen, Margaret Zurack, Debra Hanna, Laura A. Skerlos, Mark C. Sulavik, Glenn Gibson, Jeffrey W. Gage, Edmund L. Ellsworth, Michael Stier...> ;Antimicrobial Agents and Chemotherapy. 2007 Apr 1
• 33 citations
  3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
  Edmund L. Ellsworth, Tuan P. Tran, H. D. Hollis Showalter, Joseph P. Sanchez, Brian M. Watson, Michael Stier, John M. Domagala, Stephen J. Gracheck, E. Themis Joannide...> ;Journal of Medicinal Chemistry. 2006 Nov 2
• 8 citations
  Energy requirements of non-ambulatory, tube-fed adult patients with cerebral palsy and chronic hypothermia.
  Roland N. Dickerson, Rex O. Brown, Debra L. Hanna, John E. Williams> ;Nutrition. 2003 Sep 1
• 5 citations
  Effect of upper extremity posturing on measured resting energy expenditure of nonambulatory tube-fed adult patients with severe neurodevelopmental disabilities
  Roland N. Dickerson, Rex O. Brown, Debra L. Hanna, John E. Williams> ;JPEN. Journal of Parenteral and Enteral Nutrition. 2002 Sep 1
• 6 citations
  Validation of a new method for estimating resting energy expenditure of non-ambulatory tube-fed patients with severe neurodevelopmental disabilities
  Roland N. Dickerson, Rex O. Brown, Debra L. Hanna, John E. Williams> ;Nutrition. 2002 Jul 1
• 15 citations
  Topiramate and Weight Loss in Patients with Neurodevelopmental Disabilities
  Rex O. Brown, Carla D. Orr, Debra L. Hanna, John E. Williams, Roland N. Dickerson> ;Pharmacotherapy. 2002 Jul 1
• Join now to see all